Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
Open accessThe DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Background: Urothelial bladder cancer (UBC) is a highly prevalent disease in North America, however its optimal management remains elusive. The contribution of B cell associated responses is poorly understood in bladder cancer. Lymphoid neogenesis is a hallmark of an active immune response at tumor sites that sometimes leads to formation of tertiary lymphoid structures (TLS) that resemble germinal centers formed in secondary lymphoid organs. Objective: This study was conducted with an aim to investigate the presence and characteristics of TLS in UBC with a focus to compare and contrast the TLS formation in treatment naive low grade non-muscle invasive (NMIBC) and muscle invasive bladder cancers (MIBC). Methods: The study cohort consisted of transurethral bladder resection tumour (TURBT) specimens from 28 patients. Sections showing lymphoid aggregates in hematoxylin and eosin (H&E) stained TURBT specimens were further subjected to multi-color immunohistochemistry using immune cell markers specific to CD20 + B cells, CD3 + and CD8 + T cells, PNAd + high endothelial venules, CD208 + mature dendritic cells, CD21 + follicular dendritic cells to confirm the hallmarks of classical germinal centers. Results: Our pilot study investigating the presence of TLS in bladder cancer patients is the first to demonstrate that well-formed TLS are more common in aggressive high grade MIBC tumors compared to low grade NIMBC. Conclusions: These novel findings suggest B cell mediated anti-tumour humoral immune responses in bladder cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig.1 Developmental continuum of TLS in bladder tumours. Multi-color IHC performed on 5 μm thick sections from formalin fixed paraffin embedded bladder tumour tissue to reveal features associated with the TLS architecture. Different Types of aggregates and immune cell distributions were defined as previously described by Kroeger et al., [20], A) Type I B) Type 2 C) Type 3 and D) Type 4 aggregates. E) Well formed tertiary lymphoid structure in high grade muscle invasive bladder tumour showing CD3+ (green) and CD8+ T lymphocytes (purple), CD20+ B lymphocytes (pink), CD21+ follicular dendritic cells (blue), CD208+ mature dendritic cells (black), PNAd+ high endothelial venule (brown).](https://figures.cochat.ai/paper-figures/b922a8a9ffbf4dde981431cda12b46e8/tertiary-lymphoid-structures-associate-with-tumour-stage-in-urothelial-bladder-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tertiary lymphoid structures (TLS) have recently emerged as biomarkers of response to ICT across several tumor types, including lung cancer, melanoma, RCC, sarcoma, and urothelial cancer (163-167).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [165]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · cited 1×
“Significant efforts in cancer immunology have been directed towards the association of tumour infiltrating lymphocytes (TILs) with disease prognosis, a feature that is of both prognostic and predictive relevance across cancers [4, 5].”
BackgroundSpatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Dynamics of B cells in germinal centres
De Silva, N. S., & Klein, U. (2015) · Nature Reviews Immunology · doi:10.1038/nri3804 · Cited by 1,084 · cited 1×
“These extra-nodal sites of adaptive immunity are most common in autoimmune (rheumatoid arthritis) or inflammatory conditions [10, 11].”
BackgroundDieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
Bastani, R., Glenn, B. A., & Maxwell, A. E. (2015) · eCite Digital Repository (University of Tasmania) · doi:10.1158/1055-9965 · Cited by 901
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
Research works printed but not linked: 2
- De Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol [Internet]. Nature Publishing Group 2015; 15(3): 137– 48. Available from: http://dx.doi.org/10.1038/nri3804n10.1038/nri3804 PMC4399774 25656706 · doi:10.1038/nri3804n10.1038/nri3804
- Matsumoto H, Koo SL, Dent R, Tan PH, Iqbal J. Role of inflammatory infiltrates in triple negative breast cancer. J Clin Pathol. Department of Pathology, Singapore General Hospital, Singapore, Singapore Department of Pathology, Ryukyu University Hospital, Okinawa, Japan.; Department of Medical Oncology, National Cancer Centre, Singapore, Singapore.; Department of Medical Oncology;; 2015.
Cited by
Tertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
The Next Decade of Immune Checkpoint Therapy
Sharma, P., Siddiqui, B. A., Anandhan, S., Yadav, S. S., Subudhi, S. K., Gao, J., Goswami, S., & Allison, J. P. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1680 · Cited by 750
Extensive heterogeneity in somatic mutation and selection in the human bladder
Lawson, A. R. J., Abascal, F., Coorens, T. H. H., Hooks, Y., O’Neill, L., Latimer, C., Raine, K., Sanders, M. A., Warren, A. Y., Mahbubani, K. T. A., et al. (2020) · Science · doi:10.1126/science.aba8347 · Cited by 311
High endothelial venules (HEVs) in immunity, inflammation and cancer
Blanchard, L., & Girard, J.-P. (2021) · Angiogenesis · doi:10.1007/s10456-021-09792-8 · Cited by 207
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer
Sofopoulos, M., Fortis, S. P., Vaxevanis, C. K., Sotiriadou, N. N., Arnogiannaki, N., Ardavanis, A., Vlachodimitropoulos, D., Perez, S. A., & Baxevanis, C. N. (2019) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-019-02407-8 · Cited by 160
Groeneveld, C. S., Fontugne, J., Cabel, L., Bernard-Pierrot, I., Radvanyi, F., Allory, Y., & de Reyniès, A. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.036 · Cited by 160
Wennhold, K., Thelen, M., Lehmann, J. M., Schran, S., Preugszat, E., Garcia-Marquez, M. A., Lechner, A., Shimabukuro‐Vornhagen, A., Ercanoglu, M. S., Klein, F., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0949 · Cited by 127
Rodriguez, A. B., & Engelhard, V. H. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0432 · Cited by 114
Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value
Li, K., Guo, Q., Zhang, X., Dong, X., Liu, W., Zhang, A., Li, Y., Yan, J., Jia, G., Zheng, Z., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13389 · Cited by 74
Ligon, M. M., Wang, C., Jennings, Z., Schulz, C., DeJong, E. N., Lowder, J. L., Bowdish, D. M. E., & Mysorekar, I. U. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0290-x · Cited by 67
Effects of aging on urinary tract epithelial homeostasis and immunity
Ligon, M. M., Joshi, C. S., Fashemi, B., Salazar, A., & Mysorekar, I. U. (2022) · Developmental Biology · doi:10.1016/j.ydbio.2022.11.003 · Cited by 58
Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma
Wakasu, S., Tagawa, T., Haratake, N., Kinoshita, F., Oku, Y., Ono, Y., Takenaka, T., Oda, Y., Shimokawa, M., & Mori, M. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03353-8 · Cited by 49
Xu, W., Ma, C., Liu, W., Anwaier, A., Tian, X., Shi, G., Qu, Y., Wei, S., Zhang, H., & Ye, D. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03123-y · Cited by 48
Bao, J., Betzler, A. C., Heß, J., & Brunner, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233085 · Cited by 46
Hamade, A., Li, D., Tyryshkin, K., Xu, M., Conseil, G., Yolmo, P., Hamilton, J., Chenard, S. W., Siemens, D. R., & Koti, M. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00428-0 · Cited by 43
Self-citationYuan, H., Mao, X., Yan, Y., Huang, R., Zhang, Q., Zeng, Y., Bao, M., Dai, Y., Fang, B., Mi, J., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04860-1 · Cited by 44
Wahlin, S., Nodin, B., Leandersson, K., Boman, K., & Jirström, K. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1644108 · Cited by 44
Tertiary Lymphoid Structures as Mediators of Immunotherapy Response
Vaghjiani, R. G., & Skitzki, J. J. (2022) · Cancers · doi:10.3390/cancers14153748 · Cited by 37
Semeniuk-Wojtaś, A., Poddębniak-Strama, K., Modzelewska, M., Baryła, M., Dziąg-Dudek, E., Syryło, T., Górnicka, B., Jakieła, A., & Stec, R. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03376-9 · Cited by 35
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring
Berthe, J., Poudel, P., Segerer, F. J., Jennings, E. C., Ng, F., Surace, M. J., Andoni, A., Testori, M., Saraiya, M., Vuko, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422206 · Cited by 29
Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles
Ten, A., Kumeiko, V. V., Farniev, V. M., Gao, H., & Shevtsov, M. A. (2024) · Cells · doi:10.3390/cells13080682 · Cited by 27
An, Y., Sun, J., Xu, M., Xu, J., Ma, S.-Y., Liu, C., Liu, Z., Wang, S., & Xia, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049884 · Cited by 26
Ma, G., Jia, H., Zhang, G., Liang, Y., Dong, X., Fu, G., Wang, X., & Niu, H. (2023) · The Oncologist · doi:10.1093/oncolo/oyad283 · Cited by 25
Yolmo, P., Rahimi, S., Chenard, S. W., Conseil, G., Jenkins, D., Sachdeva, K., Emon, I. M., Hamilton, J., Xu, M., Rangachari, M., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-1114 · Cited by 26
Self-citationB cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer
Li, Y., Li, S., Liu, M.-C., Chen, Z., Li, L., Shen, F., Liu, Q.-Z., Xu, B., & Lian, Z.-X. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02072-w · Cited by 22
Adaptive Immunity in Genitourinary Cancers
Koti, M., Bivalacqua, T. J., Black, P. C., Cathomen, T., Galsky, M. D., Gulley, J. L., Ingersoll, M. A., Kamat, A. M., Kassouf, W., Siemens, D. R., et al. (2023) · European Urology Oncology · doi:10.1016/j.euo.2023.03.002 · Cited by 20
Self-citationProteomics as a Complementary Technique to Characterize Bladder Cancer
López-Cortés, R., Vázquez‐Estévez, S., Fernández, J. Á., & Núñez, C. (2021) · Cancers · doi:10.3390/cancers13215537 · Cited by 18
Gulinac, M., Dikov, D., Lichev, S., & Velikova, T. V. (2020) · Europe PMC (PubMed Central) · Cited by 18
CD4, CD20 and PD-L1 as Markers of Recurrence in Non-Muscle-Invasive Bladder Cancer
Semeniuk-Wojtaś, A., Modzelewska, M., Poddębniak-Strama, K., Kołaczyńska, S., Lubas, A., Górnicka, B., Jakieła, A., & Stec, R. (2023) · Cancers · doi:10.3390/cancers15235529 · Cited by 17
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
Koti, M., Morales, Á., Graham, C. H., & Siemens, D. R. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001119 · Cited by 16
Self-citationLigon, M. M., Liang, B., Lenger, S. M., Parameswaran, P., Sutcliffe, S., Lowder, J. L., & Mysorekar, I. U. (2023) · The Journal of Urology · doi:10.1097/ju.0000000000003196 · Cited by 15
Roles of Androgen Receptor Signaling in Urothelial Carcinoma
Sundi, D., Collier, K. A., Yang, Y., Diaz, D. A., Pohar, K. S., Singer, E. A., Gupta, S., Carson, W. E., Clinton, S. K., Li, Z., et al. (2024) · Cancers · doi:10.3390/cancers16040746 · Cited by 14
Tertiary lymphoid structures and their therapeutic implications in cancer
Chen, X., Wu, P., Liu, Z., Li, T., Wu, J., Zeng, Z., Guo, W., & Xiong, W. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00975-1 · Cited by 13
Teng, X., Chen, Z. B., Bai, Y., Cao, H., Zhang, J., Xu, L., Liu, K., Shi, Y., & Shao, Y. W. (2025) · Cancer Medicine · doi:10.1002/cam4.70978 · Cited by 12
Wu, F., Cao, H., Ren, S., Wu, J., Liu, X., Li, Q., Xu, Q., Chen, J., Wang, R., Chen, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1483497 · Cited by 12
Smith, M. E., Farahani, S. J., Chao, T., Palmer, M., Arriola, A. G. P., & Lal, P. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa105 · Cited by 12
Tertiary lymphoid structures, a historical reappraisal
Ribatti, D. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102288 · Cited by 11
Tertiary lymphoid structures in endometriosis
Zutautas, K. B., Yolmo, P., Xu, M., Childs, T. J., Koti, M., & Tayade, C. (2024) · F&S Science · doi:10.1016/j.xfss.2024.10.001 · Cited by 9
Self-citationA Fibromyxoid Stromal Response is Associated with Muscle Invasion in Canine Urothelial Carcinoma
de Brot, S., Grau‐Roma, L., Stirling-Stainsby, C., Dettwiler, M., Guscetti, F., Meier, D., Scase, T. J., Robinson, B. D., Gardner, D. S., & Mongan, N. P. (2019) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2019.04.003 · Cited by 9
Seki, M., Sano, T., Saito, E., Ogawa, M., Yokoo, S., & Oyama, T. (2024) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13509 · Cited by 8
Yılmaz, F., & Sağır, S. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.06.010 · Cited by 8
Tertiary Lymphoid Structures in Microorganism-Related Cancer
Deng, S., Yang, X., He, L., Hou, Y., & Meng, H. (2024) · Cancers · doi:10.3390/cancers16203464 · Cited by 8
Drachneris, J., Morkūnas, M., Fabijonavicius, M., Čekauskas, A., Jankevičius, F., & Laurinavičius, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094776 · Cited by 7
Zhang, J., Huang, Y., Tan, X. G., Wang, Z., Cheng, R., Zhang, S., Chen, Y., Jiang, F., Tan, W., Deng, X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112184 · Cited by 7
Yang, J., Xiong, X., Zheng, W., Xu, H., Liao, X., Wei, Q., & Yang, L. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001939 · Cited by 6
Siliņa, K., & Ciompi, F. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4184-2_12 · Cited by 5
Mei, S., Liu, J., Huang, Z., Luo, W., Peng, Y., Chen, Z., Deng, Y., Xu, C., & Zhou, Q. H. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15299 · Cited by 5
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer
Yang, D. D., Abdelnaser, A., Haas, A. J., Wala, J. A., Barney, A. A., Saad, E., Crowdis, J. P., Ricker, C. A., Awad, S., Gürel, B., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-4900 · Cited by 3
Tertiary Lymphoid Structure Formation and Function in the Tumor Microenvironment
MacFawn, I., & Bruno, T. C. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_83-1 · Cited by 3
The Evolving Landscape of Bladder Tertiary Lymphoid Structures
Koti, M., & Siemens, D. R. (2023) · The Journal of Urology · doi:10.1097/ju.0000000000003530 · Cited by 3
Self-citationLinehan, J., Agarwal, P. K., Penny, X., Kates, M., Jacob, J. M., Lerner, S. P., Kines, R. C., Schiller, J. T., Pinos, E. D. L., Shore, N. D., et al. (2026) · European Urology Open Science · doi:10.1016/j.euros.2026.05.017 · Cited by 2
Hu, P., Wang, C., Zeng, X., Jin, S., Huang, J., Wang, Q., Li, X. S., Du, Y., Song, Y., & Xu, T. (2026) · BMC Cancer · doi:10.1186/s12885-026-16326-2 · Cited by 2
Titov, E. V., Yakovtsova, I. I., Ивахно, И. В., Nehoduiko, V. V., Макаров, В. В., & Panasenko, S. I. (2023) · Український радіологічний та онкологічний журнал · doi:10.46879/ukroj.4.2023.391-403 · Cited by 2
Mazzucchelli, R., Cormio, A., Zanelli, M., Zizzo, M., Palicelli, A., Galosi, A. B., & Sanguedolce, F. (2025) · Applied Sciences · doi:10.3390/app152212032 · Cited by 1
Zhou, C., Chen, J., Wang, Y., Chen, L., Feng, M., Li, D., Gao, Y., Li, L., Chen, X., Hao, B., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07852-5 · Cited by 2
Lee, H. W., & Sung, H. H. (2025) · Journal of Urologic Oncology · doi:10.22465/juo.255000300015 · Cited by 1
Tertiary Lymphoid Structure Formation and Function in the Tumor Microenvironment
MacFawn, I., & Bruno, T. C. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_83 · Cited by 1
Ravenscroft, B., Yolmo, P., Chenard, S. W., Rahimi, S., Pace, K., Sachdeva, K., Jamaspishvilli, T., Ghaedi, H., Garven, A., Tyryshkin, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.562817 · Cited by 1
Self-citationYolmo, P., Sachdeva, K., Brewer, A., Pattabhi, S., Conseil, G., Abdulhamed, A., Griffin, A., Jeffs, M. A., Yu, H., Cook, D. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.01.715137 · Cited by 1
Self-citationFontugne, J. (2020) · theses.fr (ABES) · doi:10.70675/5c89c43fz33ccz469dzbfbcz5c12fad12622 · Cited by 1
The prognostic value of immunocellular infiltration of non-invasive urothelial bladder cancer
Titov, E. V. (2019) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2019-23(1)-22
Utility of High-Throughput Imaging Mass Cytometry for Cancer Research: A feasibility study
Thirumal, S., Jamzad, A., Cotechini, T., Hindmarch, C. C. T., Hardy, C., Kim, N., Simpson, A. L., Graham, C. H., Berman, D. M., Siemens, D. R., et al. (2021) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi50953.2021.9508569
Self-citationYilmaz, F., & Sağır, S. (2024) · Research Square · doi:10.21203/rs.3.rs-3962802/v1
Yilmaz, F., & Sağır, S. (2024) · Research Square · doi:10.21203/rs.3.rs-3962802/v2
Ji, J., Li, P., Yuan, T., Qu, Z., Song, G., Bao, M., Liang, X., Jiang, B., Yin, X. L., Wang, Y., et al. (2024) · International Journal of Radiation Research · doi:10.61186/ijrr.22.2.277
Clinical significance of tertiary lymphoid structure maturity in colorectal cancer patients
ZHENG, J., Yu, J., Xie, J., Chen, D., & Hong, D. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0320
Xue, T., Zhang, X., Ye, Q., Li, P., & Hu, Y. (2025) · Clinical Medicine Insights Oncology · doi:10.1177/11795549251325061
Hamade, A., Li, D., Tyryshkin, K., Xu, M., Conseil, G., Yolmo, P., Hamilton, J., Chenard, S., Robert Siemens, D., & Koti, M. (2022) · Figshare · doi:10.6084/m9.figshare.19704021
Self-citationHamade, A., Li, D., Tyryshkin, K., Xu, M., Conseil, G., Yolmo, P., Hamilton, J., Chenard, S., Robert Siemens, D., & Koti, M. (2022) · Figshare · doi:10.6084/m9.figshare.19704006
Self-citationHamade, A., Li, D., Tyryshkin, K., Xu, M., Conseil, G., Yolmo, P., Hamilton, J., Chenard, S., Robert Siemens, D., & Koti, M. (2022) · Figshare · doi:10.6084/m9.figshare.19704000
Self-citationYuan, H., Mao, X., Yan, Y., Huang, R., Zhang, Q., Zeng, Y., Bao, M., Dai, Y., Fang, B., Mi, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667193
Yuan, H., Mao, X., Yan, Y., Huang, R., Zhang, Q., Zeng, Y., Bao, M., Dai, Y., Fang, B., Mi, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667199
Eismann, L. (2023) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.32167
Yuan, H., Mao, X., Yan, Y., Huang, R., Zhang, Q., Zeng, Y., Bao, M., Dai, Y., Fang, B., Mi, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26667196
Comparative histopathological and transcriptomic evaluation of urologic cancer models
de Brot, S. (2020) · Nottingham ePrints (University of Nottingham)
Groeneveld, C. S. (2023) · theses.fr (ABES) · doi:10.70675/10c68a9dz9fcaz441ez9760zd2be90dbb9d0
Titov, Y. V., Яковцова, І. І., Ивахно, И. В., Негодуйко, В. В., Макаров, В. В., & Панасенко, С. І. (2023) · Kharkiv National Medical University Repository (Kharkiv National Medical University)
Sachdeva, K., Yolmo, P., Abdulhamed, A., Conseil, G., Rahimi, S., Berman, D. M., Tyryshkin, K., Li, R., Siemens, D. R., & Koti, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.743535
Self-citationWei, X., Pei, X., & Yu, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1853633
An, Y., Sun, J.-X., Xu, M.-Y., Xu, J.-Z., Ma, S.-Y., Liu, C.-Q., Liu, Z., Wang, S.-G., & Xia, Q.-D. (2022) · doi:10.3389/fimmu.2022.1049884.s001
Metadata
- Authors
- Koti, M., Xu, A. S., Ren, K. Y. M., Visram, K., Ren, R., Berman, D. M., & Siemens, D. R.
- Affiliations
- Queen's University (CA)
- Corresponding author
- Koti, Madhuri
- Venue
- Bladder Cancer
- Publisher
- SAGE Publications
- Published
- 2017-10-27
- Volume
- 3
- Issue
- 4
- Pages
- 259-267
- ISSN
- 2352-3727 (ISSN-L)
- 2352-3735
- PMC
- PMC5676768
- OpenAlex
- W2767198233
- Cited by
- 78
- References
- 23
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 23 · 2023: 14 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 7
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bladder Cancer (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
- Keywords
- tertiary lymphoid structures, bladder urothelial carcinoma, tumor stage, muscle-invasive bladder cancer, non-muscle-invasive bladder cancer, germinal center, B cell response, tumor immune microenvironment, high endothelial venules, follicular dendritic cells, tumor progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.